Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Earnings for Genocea Biosciences (GNCA)
Earnings in 2022 (TTM): -$37.2 M
According to Genocea Biosciences 's latest financial reports the company's current earnings (TTM) are -$37.2 M. In 2021 the company made an earning of -$33.2 M an increase over its 2020 earnings that were of -$43.72 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genocea Biosciences from 2013 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$37.2 M | 12.03% |
| 2021 | -$33.2 M | -24.06% |
| 2020 | -$43.72 M | 12.23% |
| 2019 | -$38.95 M | 40.05% |
| 2018 | -$27.82 M | -50.96% |
| 2017 | -$56.71 M | 14.4% |
| 2016 | -$49.58 M | 16.69% |
| 2015 | -$42.49 M | 20.36% |
| 2014 | -$35.3 M | 69.64% |
| 2013 | -$20.81 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -8,884.38% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -8,260.58% | 🇺🇸 USA |
 Novavax NVAX | -$0.53 B | 1,321.35% | 🇺🇸 USA |
 Agenus
AGEN | -$0.16 B | 328.90% | 🇺🇸 USA |
 iBio IBIO | -$20.67 M | -44.45% | 🇺🇸 USA |